BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8560198)

  • 1. Effect of 12 neutralizing anti-cytokine antibodies on in vitro activation of B-cells. Interleukin-12 is required by B1a but not B2 cells.
    Jones BM
    Scand J Immunol; 1996 Jan; 43(1):64-72. PubMed ID: 8560198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
    Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
    Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5+ B-lymphocytes are as dependent on T-helper cells and as responsive to T-suppressor cells in pokeweed mitogen-stimulated activation as conventional CD5- B-lymphocytes.
    Jones BM
    Scand J Immunol; 1991 Apr; 33(4):387-92. PubMed ID: 1708165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
    Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
    Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens.
    Zupo S; Dono M; Azzoni L; Chiorazzi N; Ferrarini M
    Eur J Immunol; 1991 Feb; 21(2):351-9. PubMed ID: 1705511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells: possible involvement in age-associated cytokine dysregulation.
    Spencer NF; Daynes RA
    Int Immunol; 1997 May; 9(5):745-54. PubMed ID: 9184920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CD5 and other differentiation antigens on human immunoglobulin-secreting cells using a combination of immunobead rosetting and reverse haemolytic plaque formation.
    Jones BM
    J Immunol Methods; 1990 Aug; 132(1):119-26. PubMed ID: 1697320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
    Jones BM; Cheng IK; Wong RW
    Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5+ B cell-dependent regulation of the murine T-cell independent immune response against the human blood group A antigen.
    NĂ©ron S; Lemieux R
    Immunol Invest; 1997; 26(5-7):631-47. PubMed ID: 9399105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
    Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
    Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
    Tangye SG; Weston KM; Raison RL
    Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Cell Alloantigen 1 and IL-10 Secretion Define Two Distinct Peritoneal B1a B Cell Subsets With Opposite Functions, PC1
    Schumacher A; Ehrentraut S; Scharm M; Wang H; Hartig R; Morse HC; Zenclussen AC
    Front Immunol; 2018; 9():1045. PubMed ID: 29868008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
    Tangye SG; Weston KM; Raison RL
    Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal cavity CD5 (Bla) B cells: cytokine induced IgA secretion and homing to intestinal lamina propria in SCID mice.
    Beagley KW; Murray AM; McGhee JR; Eldridge JH
    Immunol Cell Biol; 1995 Oct; 73(5):425-32. PubMed ID: 8595920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Liu E; Peter K; Tipping P; Toh BH; Bobik A; Kyaw T
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
    Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
    J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
    Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5 blockade enhances ex vivo CD8
    Alotaibi F; Rytelewski M; Figueredo R; Zareardalan R; Zhang M; Ferguson PJ; Maleki Vareki S; Najajreh Y; El-Hajjar M; Zheng X; Min WP; Koropatnick J
    Eur J Immunol; 2020 May; 50(5):695-704. PubMed ID: 31943150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood group antibodies are made by CD5+ and by CD5- B cells.
    Wuttke NJ; Macardle PJ; Zola H
    Immunol Cell Biol; 1997 Oct; 75(5):478-83. PubMed ID: 9429896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of porcine CD5 and CD5+ B cells.
    Appleyard GD; Wilkie BN
    Clin Exp Immunol; 1998 Jan; 111(1):225-30. PubMed ID: 9472686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.